Herein, results revealed that KCNQ1OT1 could aggravate the malignant behaviors of CC and facilitate tumor growth through modulating miR-296-5p/HYOU1 axis, consequently developing promising molecular targets for CC therapeutics. This evidence concerns the gene KCNQ1OT1 and neoplasm.